Postoperative Complications After Cleft Palate Closure in Patients With Pierre Robin Sequence: Operative Considerations
NCT ID: NCT02658318
Last Updated: 2016-01-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
92 participants
OBSERVATIONAL
2011-01-31
2015-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators aim to retrospectively review the charts of all cleft patients, both PRS and non-PRS, treated with an adapted Furlow palatoplasty between 01/01/2011 and 31/08/2015. The incidence of peri- and postoperative complications, with a specific focus on respiratory complications, will be examined. The value of demographic, surgical and postoperative parameters will be examined as potential risk factors for the development of complications.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Length of Hospital Stay and Postoperative Analgesic Requirements After Introduction of a Specific Maxillary Nerve Block in Children Undergoing Cleft Palate Surgery
NCT07279883
Clinical Effectiveness of Late Maxillary Protraction for Cleft Lip and Palate
NCT02789787
Validation of a Production Method of Stem Cell Isolated From the Nasal Cavity for an Innovative Cell Therapy of Cleft Palate
NCT02900014
Prevention of Post Operative Bone Loss in Children
NCT00655681
The Prevalence and Risk Factors of Coagulopathy in Pediatric Epilepsy Surgery Patients
NCT05675254
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pierre Robin Syndrome (PRS)
Cleft palate patients with the Pierre Robin Syndrome.
No interventions assigned to this group
non-PRS
Cleft palate patients without the Pierre Robin Syndrome.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients that had undergone a modified Furlow palatoplasty
* patients treated at the GH Saint-John Bruges (Belgium), or the cooperating Semmelweis University (Hungary)
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AZ Sint-Jan AV
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Johan Abeloos
Maxillofacial surgeon, Head of Department
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Johan Abeloos, MD
Role: PRINCIPAL_INVESTIGATOR
Maxillofacial surgeon, Head of Department
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
General Hospital Saint-John Bruges
Bruges, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B049201525560
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.